holdings2017bb – Page 5

European Haematology Association (EHA) meeting

June 11, 2015

A forum for presenting original unpublished data and sharing ideas for haematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance. 11 – 14 June Vienna, Austria Visit the EHA website here See the program here

British Cardiovascular Society Annual Conference 2015 (BCS 2015)

June 8, 2015

8 – 10 June Manchester, UK Visit the BCS website here See the program here

Nordic Baltic Congress of Cardiology 2015 (NBCC 2015)

June 4, 2015

4 – 6 June Swissôtel, Tallinn, Estonia Visit the NBCC website here See the program here

Italian National Congress Of Cardiology 2015 (ANMCO 2015)

June 4, 2015

4 – 6 June Marriot Hotel, Milan, Italy Visit the ANMCO website here Currently no program information available

Joint European Society for Microcirculation & 8th European Vascular Biology Organisation Meeting

June 3, 2015

3 – 6 June Polo Carmignani Piazza dei Cavalieri, Pisa, Italy Visit the ESM-EVBO website here See the program here

Slovenian Society of Cardiology – Alpe Adria Cardiology Meeting

June 3, 2015

3 – 6 June Bled, Slovenia Visit the AACardio website here See the program here

UK NEQAS for Blood Coagulation Scientific Meeting

June 3, 2015

An international External Quality Assessment (EQA) programme offering independent impartial assessment of performance with a comprehensive range of coagulation testing for laboratories and individuals worldwide. 3 – 4 June Royal Hallamshire Hospital, Sheffield, UK Visit the UK NEQAS website here

Divestment of portfolio of branded and generic products to Strides entities

May 21, 2015

21/05/15: Aspen is pleased to announce that certain of its wholly owned Australian subsidiaries (collectively “Aspen Australia”), have entered into an agreement with Strides (Australia) Pharma Pty Ltd (“Strides Australia”), a company incorporated in Australia, in terms whereof Aspen Australia will divest to Strides Australia, a portfolio of approximately 130 products for a consideration of…

Cautionary Announcement

May 14, 2015

14/05/15: Shareholders are advised that Aspen is currently engaged in discussions regarding a possible acquisition of an infant nutritionals business. These discussions may have a material effect on the price of Aspen’s securities if successfully concluded and accordingly shareholders are advised to exercise caution when dealing in the Company’s securities. Durban 14 May 2015 Sponsor …

Divestment of South African Business Unit to Litha

May 11, 2015

11/05/15: Aspen is pleased to announce that Pharmacare Limited (“Pharmacare”), a wholly owned subsidiary of Aspen Holdings and the Group’s primary South African trading company, has concluded a set of agreements with Litha Pharma (Pty) Ltd (“Litha”) (a wholly owned South African subsidiary of Endo International Plc) in terms which Pharmacare will divest a business…